DUARTE, Calif., October 8, 2012 — Dennis Weisenburger, M.D., an internationally recognized authority on blood diseases, joined City of Hope as chair and professor in the Department of Pathology. His appointment as pathology chair serves to continue City of Hope’s long history of academic leadership and excellence in pathology and hematopathology, initially begun by our former Department of Pathology Chair Henry Rappaport, M.D., who developed the Rappaport Classification, the first clinically significant lymphoma classification system.
“We are honored to bring Dennis Weisenburger to City of Hope as our new chair of pathology, and I look forward to many years of mutual success and excellence,” said Alexandra Levine, M.D., M.A.C.P., chief medical officer and Dr. Norman & Melinda Professor of Medicine, City of Hope. “This is a great homecoming for Dr. Weisenburger, who began his in hematopathology here at the institution, first as a fellow and then assistant pathologist.”
Prior to joining City of Hope, Weisenburger was a professor of pathology and microbiology at the University of Nebraska Medical Center in Omaha. He has contributed significantly to the field of pathology and malignant hematology, and holds two patents for his work in lymphoma prognosis. Weisenburger has published widely in peer-reviewed journals, with more than 330 articles to his credit. He also has authored or co-authored more than 500 abstracts and 34 book chapters.
In addition, he helped develop the Nebraska Lymphoma Study Group and served as chief pathologist for the collaborative clinical research network. He’s received international recognition related to his work on classification of Hodgkin and non-Hodgkin lymphoma.
A graduate of the University of Minnesota Medical School, Weisenburger received his Bachelor of Arts (Phi Beta Kappa) and Bachelor of Science degrees from the University of North Dakota. He completed an internship in internal medicine at The Ohio State University Hospital in Columbus, a residency in anatomic and clinical pathology at the University of Iowa Hospitals in Iowa City, and a fellowship in hematopathology at City of Hope.
